FindTrial
Sign In

Feasibility Study for Malaria Vaccine Development

Feasibility of Conducting Human Sporozoite Infection and Challenge Studies in Healthy Adult Malaria Naive Volunteers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/12/004254
Enrollment
100
Registered
2013-12-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Malaria Vaccine Development Program
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Ability to give informed consent 2. Secure more than or equal to 70 percent marks in â??Comprehension Check Questionnaireâ??

Exclusion criteria

Exclusion criteria: Inability to give informed consent

Design outcomes

Primary

MeasureTime frame
1. To undertake a feasibility analysis that will assist in determining the potential of successfully meeting enrollment requirements for Human Sporozoite Infection and Challenge Studies in Healthy Adult Malaria Naive Volunteers 2. To study the seropositivity to Plasmodia parasites in the identified population 3. To utilize the gathered information/data to better design sporozoite infection and challenge studies Timepoint: End of the study—

Secondary

MeasureTime frame
1. To determine history of allergy to antimalarial drugs 2. To determine any history of immediate type hypersensitivity reactions to mosquito bites Timepoint: End of study—

Countries

India

Contacts

Public ContactMd Muneeb Ahsan

Malaria Vaccine Development Program (MVDP)

shantanu.mehta@mvdp.org.in011-26741331

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026